Join us at the webinar on Oct. 22 to understand which criteria to consider for molecular testing.
Join us at the webinar on Oct. 23rd to learn more about how to implement Ex Vivo technology in your practice.
Read ASCO’s endorsement of the CAP/IASLC/AMP lung cancer biomarker guideline in the Journal of Clinical Oncology.
On November 5, attendees will learn about the final rule’s pathology-related details, reimbursement changes affecting pathologists, and the CAP’s advocacy efforts for these issues.
Join us on November 6th for our interactive, case-based webinar worth 1.5 CME that will answer your common questions and challenges related to HER2 and ER/PgR testing.
In This Month’s Issue: Virus or bacterium? Gene expression may tell; Risk management steps up labs’ QC game under IQCP; Study: primary HPV test ‘merits consideration’